Biotechnologist Craig Venter — the first scientist to map out the human genome and create synthetic sprightliness — now wants to dramatically extend the human life . His new troupe , Human Longevity Inc. , will use both genomics and stem jail cell therapy to serve people appease healthy and vivacious for as long as potential .
This news come seven month afterGoogle ’s announcement that it had founded a similar company , Calico — a startup that will focus on health , well - being , and extending the human life-time . The embodied race to prolong life , it would seem , is begin to heat up up . And justifiedly so ; there ’s a ton of money to be made — and redeem — through preventative medicines .
Venter , along with stem cell innovator Robert Hariri and X Prize Foundation founder Peter Diamandis , are hop-skip to see the startup make a spate of new find .
“ We think this will have a huge impact on changing the cost of medicine , ” Venter said on a conference call announcing the speculation .
To date , the caller has get $ 70 - million in private backing . It ’s even procured two ultrafast HiSeq X Ten cistron sequencing systems from Illumina Inc , a leading manufacturing business of DNA sequence machine , with the alternative to buy three more . The technology will be used to map the 40,000 human genomes as the caller builds the domain ’s orotund database of human genic variation . It will contain sequences from the very youthful through to the very old , both pathologic and goodly .
“ This will be one of the large information study in the chronicle of science and medicine , ” sound out Venter .
Remarkably , the startup will also gather whole genome datum on the jillion of microbe that populate the human torso , including bacterium , virus , and fungi . The goal is to develop better probiotics and diagnostic prick and drug to ameliorate health and wellness .
ab initio , the society plans to address some of the tough age - refer diseases , namely cancer , diabetes and fleshiness , heart and liver disease , and dementia .
“ Using the combined power of our essence areas of expertness — genomics , information science , and prow cell therapy , we are tackling one of the greatest medical / scientific and societal challenge — ripening and aging related to disease , ” noted Venter in arelease . “ HLI is going to modify the agency medicine is practice by helping to shift to a more preventive , genomic - based medicine role model which we believe will lower healthcare costs . Our goal is not necessarily lengthen living , but extending a levelheaded , high playing , more fertile living span . ”
Methinks Venter is being both insincere and lowly . By tackle these problem in this way , his company is very well positioned to become a loss leader in the growing of bona fide life extension technologies . It ’s possible Venter is avoiding the seemingly extremist talk about “ not necessarily lengthening life ” to maintain credibility . But establish on Venter ’s study in the past times , it ’s clear this bozo is thinking swelled .
[ ViaReuters ]
Image : Craig Venter Institute .
FuturismGenomicsScience
Daily Newsletter
Get the best tech , science , and culture tidings in your inbox daily .
News from the future , delivered to your present tense .
Please take your desired newssheet and submit your email to upgrade your inbox .
You May Also Like
